Insider Trading Summary for Cullinan Therapeutics, Inc. (CGEM): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
11-Jun-24 6:00 PM View:	10-Jun-24 Option Exercise $239.85K	Ebeling Thomas Director		Cullinan Therapeutics, Inc. - CGEM	177% 67.5K to 186.65K	0	0	--	--	Show Txns Hide Txns

23-Feb-24 5:00 PM View:	22-Feb-24 Grant 0	Trigilio Jeffrey Chief Financial Officer		Cullinan Therapeutics, Inc. - CGEM	52% 88.16K to 133.92K	0	0	--	--	Show Txns Hide Txns

23-Feb-24 5:00 PM View:	22-Feb-24 Grant 0	Ahmed Nadim President and CEO Director		Cullinan Therapeutics, Inc. - CGEM	134% 115.82K to 271.55K	0	0	--	--	Show Txns Hide Txns

23-Feb-24 5:00 PM View:	22-Feb-24 Grant 0	Jones Jeffrey Alan Chief Medical Officer		Cullinan Therapeutics, Inc. - CGEM	103% 58.44K to 118.69K	0	0	--	--	Show Txns Hide Txns

23-Feb-24 5:00 PM View:	22-Feb-24 Grant 0	Sumer Jacquelyn L Chief Legal Officer		Cullinan Therapeutics, Inc. - CGEM	105% 45.82K to 94.13K	0	0	--	--	Show Txns Hide Txns

23-Feb-24 5:00 PM View:	22-Feb-24 Grant 0	Savill Corrine Chief Business Officer		Cullinan Therapeutics, Inc. - CGEM	20% 170.12K to 203.49K	0	0	--	--	Show Txns Hide Txns

09-Sep-24 5:30 PM View:	05-Sep-24 Private Sale (Planned) ($144.72K)	Michaelson Jennifer Chief Scientific Officer		Cullinan Therapeutics, Inc. - CGEM	29% 90.03K to 115.94K	0	0	--	--	Show Txns Hide Txns

Buy:	0	--
Sell:	0	--